naltrexone has been researched along with chronic COVID syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonilla, A; Bonilla, H; Eggert, L; Geng, LN; Marconi, VC; McComsey, GA; Miglis, M; Shafer, R; Tian, L; Yang, P | 1 |
1 other study(ies) available for naltrexone and chronic COVID syndrome
| Article | Year |
|---|---|
Low-dose naltrexone use for the management of post-acute sequelae of COVID-19.
Topics: COVID-19; Disease Progression; Humans; Naltrexone; Post-Acute COVID-19 Syndrome; SARS-CoV-2 | 2023 |